Delivered by Ingenta to:
Indian Association for the Cultivation of Science (IACS)
IP : 202.54.54.240
Mon, 10 Aug 2009 04:13:43
Copyright © 2009 American Scientific Publishers
All rights reserved
Printed in the United States of America
Journal of
Nanoscience and Nanotechnology
Vol. 9, 5567–5571, 2009
Nanoparticle–Virus Complex Shows Enhanced
Immunological Effect Against Baculovirus
Ayesha Rahman
1
, Nupur Biswas
2
, Christian Ulrichs
3
, Carmen Büttner
3
,
Ratan Lal Bramhachary
1
, Arunava Goswami
1 ∗
, and Alokmay Datta
2
1
Biological Sciences Division, Indian Statistical Institute, 203, B. T. Road, Kolkata 700108, India
2
Suface Physics Division, Saha Institute of Nuclear Physics, 1/AF, Bidhannagar, Kolkata 700064, India
3
Humboldt-Universität zu Berlin, Institute for Horticultural Science, Lentzeallee 55/57, 14195 Berlin, Germany
Insects protect themselves from majority of infections by a non-specific innate immune system
(present in both vertebrates and invertebrates). Bombyx mori nuclear polyhedrosis virus (BmNPV),
a baculovirus, causing the deadly grasserie disease is a scourge to silkworm industry and we
report here the first success in combating this disease with the help of a nanosilica–virus complex.
Hydrophobic aluminium silicate nanoparticles were mixed with live BmNPV in vitro. This mixture was
injected into one day old 5th instar silkworm larvae (into the hemocoel at the third abdominal spir-
acle) before challenging the larvae with live BmNPV via a second injection. This led to substantial
enhancement of longevity in the diseased silkworm larvae and 35 ± 53% larvae completed their life-
cycle (i.e., formed normal pupae and enclosed as moth). On the other hand, 100% larvae infected
with BmNPV alone died within 36 hours. The larvae treated with nanoparticles before infection had
a longer lifespan but all of them eventually succumbed, not a single larva metamorphosed to adult
stage. Results suggest two pathways of host protective response—one mediated by nanoparticle-
alone and the second, more important, via non-specific innate immunological mechanism. AFM and
confocal studies show that nanoparticles alter 3-D molecular structure of the virus envelope. Possi-
bly this exhibits novel potent epitope(s) which stimulate(s) anti-viral machinery in infected silkworm
larvae. SDS-PAGE results suggest that 39 KDa viral protein is the major target of the nanoparticles.
Keywords: BmNPV, Nuclear Polyhedrosis Virus, Nanoparticle, Bombyx mori, Grasserie
Disease, Insect Immunity.
1. INTRODUCTION
Bombyx mori nuclear polyhedrosis virus (BmNPV) is
a circular double stranded DNA virus belonging to the
family baculoviridae. The pathogenicity of baculovirus is
confined to the invertebrates, especially in lepidopteran
insects. In nature, infection occurs when occluded bodies
(OBs) are ingested by silkworm larvae via oral route. OBs
in the milieu of alkaline gut juice (pH 9.5–11.5) release
polyhedra derived virion (PDV). PDVs enter the cells fus-
ing directly with the plasma membrane of the microvilli.
1 2
Neutralization of BmNPV infection using anti-PDV anti-
bodies has been demonstrated implying that the process
of attachment and entry might be receptor mediated.
3
BmNPV causes primary infection in the midgut colum-
nar epithelial cells followed by a systemic lethal spread in
a number of silkworm organ tissues where progeny OBs
∗
Author to whom correspondence should be addressed.
are formed. OBs can withstand adverse environments and
reestablish infection cycle when OBs from dead host con-
taminate silkworm feed.
3
Penetration of the peritrophic
membrane by PDV (after mid gut infection) is known
to be enhanced by a proteinaceous viral factor.
4
In cell
culture, 24 hours post infection, a large number of bud-
ded virions (BVs) leave the host nuclei via budding of
the nuclear membrane. BVs are responsible for the spread
of infection in different tissues of silkworm.
5
BVs are
released in the hemocoel and the generalized infection pro-
cess ensues. At the later stages of infection, BV produc-
tion terminates. In stead, PDVs are produced, occluded in
the OBs and released from dead larvae to the environ-
ment. Until now, no specific antiviral antidote, therapeutic
or prophylactic, exists. In recent years, depending on the
tunability of physico-chemical properties (such as surface
chemistry, size, solubility etc.), nanoparticles have been
used in numerous biomedical applications from targeted
drug/antibody delivery to imaging.
6 7
Here we show that
J. Nanosci. Nanotechnol. 2009, Vol. 9, No. 9 1533-4880/2009/9/5567/005 doi:10.1166/jnn.2009.1198 5567